Hennion & Walsh Asset Management, Inc. Kura Oncology, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 122,915 shares of KURA stock, worth $908,341. This represents 0.05% of its overall portfolio holdings.
Number of Shares
122,915
Previous 124,169
1.01%
Holding current value
$908,341
Previous $2.43 Million
55.89%
% of portfolio
0.05%
Previous 0.12%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
186Shares Held
81.7MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$56.6 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$51.5 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$42.9 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$40 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$32 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $494M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...